Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL229743 | 1.00 | LMNA (0.73) | LMNATDP1CYP2A6L3MBTL1APP | |
| SCHEMBL1773526 | 1.00 | LMNA (0.73) | LMNATDP1CYP2A6L3MBTL1APP | |
| SCHEMBL17444732 | 0.98 | TDP1 (0.74) | LMNATDP1CYP2A6L3MBTL1APP | |
| SCHEMBL565591 | 0.98 | TDP1 (0.74) | LMNATDP1CYP2A6L3MBTL1APP | |
| SCHEMBL565590 | 0.98 | TDP1 (0.74) | LMNATDP1CYP2A6L3MBTL1APP | |
| SCHEMBL20424557 | 0.85 | LMNA (0.71) | LMNATDP1L3MBTL1KMT2ANPSR1 | |
| SCHEMBL20424555 | 0.85 | LMNA (0.71) | LMNATDP1L3MBTL1KMT2ANPSR1 | |
| SCHEMBL12469222 | 0.85 | LMNA (1.00) | LMNATDP1KMT2AAKR1C3 | |
| SCHEMBL147065 | 0.85 | LMNA (1.00) | LMNATDP1KMT2AAKR1C3 | |
| SCHEMBL901344 | 0.85 | LMNA (1.00) | LMNATDP1KMT2AAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018210-B2 | Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing an acidic composition in the wellbore | DORF KETAL CHEMICALS FZE (AE) | 2024-06-25 | — | — | US | claimed |
| US-20240191128-A1 | Methods for Stimulating a Hydrocarbon-bearing Formation by Perforating a Wellbore and Introducing an Acidic Composition in the Wellbore | DORF KETAL CHEMICALS FZE (AE) | 2024-06-13 | — | — | US | claimed |
| US-20230227750-A1 | PROFRAGRANCE CONJUGATES | INT FLAVORS & FRAGRANCES INC (US) | 2023-07-20 | — | — | US | claimed |
| CN-116283584-A | Decenoic acid ester compound and preparation method and application thereof | 波顿香料股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| US-20230125900-A1 | Downhole Methods | HSBC BANK MIDDLE EAST LIMITED (AE) | 2023-04-27 | — | — | US | claimed |
| US-20230120003-A1 | Methods for Stimulating a Hydrocarbon-bearing Formation by Perforating a Wellbore and Introducing an Acidic Composition in the Wellbore | HSBC BANK MIDDLE EAST LIMITED (AE) | 2023-04-20 | — | — | US | claimed |
| EP-4161472-A1 | PROFRAGRANCE CONJUGATES | International Flavors & Fragrances Inc. (US) | 2023-04-12 | — | — | EP | claimed |
| US-11591511-B2 | Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing and acidic composition in the wellbore | FLUID ENERGY GROUP LTD (CA) | 2023-02-28 | — | — | US | claimed |
| CN-115697279-A | Pro-fragrance conjugates | 国际香精香料公司 | 2023-02-03 | — | — | CN | claimed |
| US-20210238469-A1 | CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES | CAMERON INTERNATIONAL CORPORATION | 2021-08-05 | — | — | US | claimed |
| US-20100087340-A1 | Methods and Compositions for Inhibiting Metal Corrosion | HALLIBURTON ENERGY SERVICES, INC. | 2010-04-08 | — | — | US | claimed |
| US-20080227668-A1 | Corrosion-inhibiting additives, treatment fluids, and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2008-09-18 | — | — | US | claimed |
| US-20080227669-A1 | Corrosion-inhibiting additives, treatment fluids, and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2008-09-18 | — | — | US | claimed |
| WO-2008071928-A2 | CORROSION INHIBITOR INTENSIFIER COMPOSITIONS AND ASSOCIATED METHODS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2008-06-19 | — | — | WO | claimed |
| US-20080139414-A1 | Corrosion inhibitor intensifier compositions and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2008-06-12 | — | — | US | claimed |
| EP-1929072-A1 | CORROSION INHIBITOR COMPOSITIONS AND ASSOCIATED METHODS | Halliburton Energy Services, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070071887-A1 | Methods of inhibiting corrosion of a metal surface | HALLIBURTON ENERGY SERVICES, INC. | 2007-03-29 | — | — | US | claimed |
| WO-2007034155-A1 | CORROSION INHIBITOR COMPOSITIONS AND ASSOCIATED METHODS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2007-03-29 | — | — | WO | claimed |
| US-20070069182-A1 | Corrosion inhibitor compositions and associated methods | HALLIBURTON ENERGY SERVICES, INC. | 2007-03-29 | — | — | US | claimed |
| US-20050123437-A1 | Methods and compositions for inhibiting metal corrosion | HALLIBURTON ENERGY SERVICES, INC. | 2005-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238469-A1 | CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES | AOC1, C5, C9 | LMNA 4048/4885TDP1 2101/4885CYP2A6 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.